An Exploratory Phase 1b/2a Multicenter, Open-Label, Novel-Novel Combination Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of CC-92480 (BMS-986348) in Novel Therapeutic Combinations in Participants with Relapsed or Refractory Multiple Myeloma (CA057003)

Principal Investigator

Dr Karthik Ramasamy

Contact us

Email: Latephasehaematology@ouh.nhs.uk

IRAS number

1005265